戻る Agenda
Session 3 : Utilization of the J-PACMP system for Cell and Gene Therapy Products
Session Chair(s)
Teruyo Arato, PhD
Professor, Clinical Research and Medical Innovation Center
Hokkaido University Hospital, Japan
Ryutaro Hirasawa
CMC Regulatory Affairs, Manager
Daiichi Sankyo Co., Ltd., Japan
Speaker(s)
jun Matsumoto
Pharmaceutical and Medical Devices Agency, Japan
Review Director, Department of Cellular and tissue derived products
Yuriko Ishii
Daiichi Sankyo Co., Ltd, Japan
Associate Director, CMC Reguratory Affairs Department
Keigo Kawabe
Sumitomo Pharma Co.,Ltd., Japan
Quality Officer, Regenerative & Cellular Medicine Office
Naoyuki Hanada
Novartis Pharma K.K., Japan
Regulatory CMC